{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:47:55Z","timestamp":1777924075617,"version":"3.51.4"},"reference-count":50,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Cutaneous squamous cell carcinoma (cSCC) is the second most common cutaneous neoplasm, and its incidence is on the rise. While most cSCCs have an excellent prognosis, certain risk factors, especially immunosuppression, have been associated with higher rates of local recurrence (LR), metastasis, and poor prognosis. This study aims to assess the risk factors for LR and metastasis development in cSCC among solid organ transplant recipients (SOTRs) and compare these rates with those in immunocompetent patients. Materials and Methods: A retrospective observational study included cSCC cases from the University Hospital Reina Sof\u00eda in C\u00f3rdoba, Spain, between 2002 and 2019. Demographic, clinical, and histopathological data were collected. Local recurrence and metastasis rates were analyzed, along with progression-free survival. Univariate analyses were performed to identify prognostic factors in SOTRs. Results: Among 849 cSCC cases, we found higher rates of local recurrence and metastasis in tumors developed by SOTRs compared to those in immunocompetent individuals. However, no significant differences in local recurrence, metastasis, or progression-free survival were observed between the two groups. Risk factors for adverse outcomes in SOTRs included tumor size &gt; 2 cm, depth &gt; 4 mm, and a higher Clark level. A total of 34.4% of SOTRs developed a second primary cSCC during the follow-up. Conclusions: In our study, cSCCs in SOTRs did not exhibit statistically significant differences in the rates of adverse outcomes compared to immunocompetent patients. The prognosis of cSCCs in SOTRs may be more related to other tumor-dependent risk factors than to the immunosuppression status itself. Future studies are needed to refine risk stratification and follow-up protocols to ensure the optimal management of high-risk cSCC cases, particularly among immunosuppressed patients.<\/jats:p>","DOI":"10.3390\/jcm12247619","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T14:12:51Z","timestamp":1702303971000},"page":"7619","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7210-8959","authenticated-orcid":false,"given":"Rafael","family":"Salido-Vallejo","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Clinic of Navarra, 31008 Pamplona, Spain"},{"name":"Department of Dermatology, Reina Sof\u00eda University Hospital, 14004 C\u00f3rdoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Escribano-Castillo","sequence":"additional","affiliation":[{"name":"School of Medicine, University of C\u00f3rdoba, 14004 C\u00f3rdoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-5044","authenticated-orcid":false,"given":"Javier","family":"Anto\u00f1anzas","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Clinic of Navarra, 31008 Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Rold\u00e1n-C\u00f3rdoba","sequence":"additional","affiliation":[{"name":"School of Medicine, University of C\u00f3rdoba, 14004 C\u00f3rdoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8013-7530","authenticated-orcid":false,"given":"Antonio","family":"Velez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Reina Sof\u00eda University Hospital, 14004 C\u00f3rdoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyre","family":"Aguado-Gil","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Clinic of Navarra, 31008 Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte Carcinomas: Current Concepts and Future Research Priorities","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamadermatol.2022.5508","article-title":"Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality with Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis","volume":"159","author":"Zakhem","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zavdy, O., Coreanu, T., Bar-On, D.Y., Ritter, A., Bachar, G., Shpitzer, T., Kurman, N., Mansour, M., Ad-El, D., and Rozovski, U. (2023). Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients-A Comparison between Different Immunomodulating Conditions. Cancers, 15.","DOI":"10.3390\/cancers15061764"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/ijd.15813","article-title":"Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia: A systematic review of the literature","volume":"61","author":"Lai","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/2013.jamadermatol.245","article-title":"Recurrence After Treatment of Cutaneous Basal Cell and Squamous Cell Carcinomas in Patients Infected with Human Immunodeficiency Virus","volume":"149","author":"Hausauer","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/ajt.14382","article-title":"Skin Cancers in Organ Transplant Recipients","volume":"17","author":"Mittal","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jdv.16025","article-title":"Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance\u2014The impact of immunosuppression on frequency of cSCC","volume":"33","author":"Plasmeijer","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/ijd.16070","article-title":"Risk factors and prevention strategies for cutaneous squamous cell carcinoma in transplant recipients","volume":"61","author":"Urso","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/TP.0000000000003827","article-title":"Keratinocyte Cancer Mortality in Kidney Transplant Recipients","volume":"106","author":"Shao","year":"2022","journal-title":"Transplantation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamadermatol.2017.4506","article-title":"Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared with Immunocompetent Patients","volume":"154","author":"Cheng","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaad.2022.08.050","article-title":"Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease","volume":"87","author":"Murad","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","first-page":"1429","article-title":"Immunosuppressed patients are at increased risk of local recurrence, metastasis, and disease specific death from cutaneous squamous cell carcinoma","volume":"315","author":"Lopez","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref_16","unstructured":"Schmults, C.D., Blitzblau, R., Aasi, S.Z., Alam, M., Amini, A., Baumann, B.C., Bordeaux, J., Chen, P., Chin, R., and Contreras, C. (2023). NCCN Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Network."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2020.01.008","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2","volume":"128","author":"Stratigos","year":"2020","journal-title":"Treat. Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: A prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcms.2009.07.007","article-title":"Cutaneous head and neck SCCs and risk of nodal metastasis\u2014UK experience","volume":"37","author":"Mourouzis","year":"2009","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2340\/00015555-1501","article-title":"Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: Analysis of a defined population","volume":"93","author":"Roozeboom","year":"2013","journal-title":"Acta Derm. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: A 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women\u2019s Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/jamadermatol.2023.2029","article-title":"Rates of Second Tumor, Metastasis, and Death from Cutaneous Squamous Cell Carcinoma in Patients with and without Transplant-Associated Immunosuppression","volume":"159","author":"Gjersvik","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2021.09.067","article-title":"Cumulative incidence and disease-specific survival of metastatic cutaneous squamous cell carcinoma: A nationwide cancer registry study","volume":"86","author":"Tokez","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.02.1155","article-title":"Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013","volume":"75","author":"Garrett","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2340\/00015555-2901","article-title":"Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients","volume":"98","author":"Genders","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jdv.15396","article-title":"Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: Is there a difference? A systematic review and meta-analysis","volume":"33","author":"Genders","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/jamadermatol.2015.1702","article-title":"Outcomes of Patients with Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study","volume":"151","author":"Levine","year":"2015","journal-title":"JAMA Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamadermatol.2018.4406","article-title":"Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients","volume":"155","author":"Lanz","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaad.2021.01.063","article-title":"Factors predicting outcomes of patients with high-risk squamous cell carcinoma treated with Mohs micrographic surgery","volume":"85","author":"Matsumoto","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/hed.25663","article-title":"Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence","volume":"41","author":"Arbab","year":"2019","journal-title":"Head Neck"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cncr.30601","article-title":"A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaad.2022.06.1169","article-title":"Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death","volume":"88","author":"Soleymani","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaad.2019.06.1303","article-title":"Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study","volume":"82","author":"Tschetter","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40463-019-0374-3","article-title":"Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck","volume":"48","author":"Phillips","year":"2019","journal-title":"J. Otolaryngol. Head. Neck Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.6002\/ect.2018.0238","article-title":"Type of Organ Transplanted Impacts the Risk and Presentation of Cutaneous Squamous Cell Carcinoma in Transplant Recipients","volume":"18","author":"Puza","year":"2020","journal-title":"Exp. Clin. Transpl."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamadermatol.2019.0692","article-title":"Incidence and Risk Factors of Keratinocyte Carcinoma after First Solid Organ Transplant in Ontario, Canada","volume":"155","author":"Park","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2021.07.065","article-title":"Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication","volume":"86","author":"Dusendang","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2017.76.6691","article-title":"Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results","volume":"36","author":"Dantal","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjd.18094","article-title":"Declining incidence of keratinocyte carcinoma in organ transplant recipients","volume":"181","author":"Menzies","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/ajd.13821","article-title":"A long-term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients","volume":"63","author":"Allnutt","year":"2022","journal-title":"Australas. J. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.transproceed.2023.06.016","article-title":"Oral Nicotinamide for Actinic Keratosis Prevention in Kidney Transplant Recipients: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial","volume":"55","author":"Zhang","year":"2023","journal-title":"Transplant. Proc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaad.2022.02.039","article-title":"Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: A randomized, double-blind, placebo-controlled pilot trial","volume":"87","author":"Chong","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Linkous, C., Strat, N., Shope, C., Andrews, L., and Lee, L.W. (J. Am. Acad. Dermatol., 2023). Analysis of Metformin, Niacinamide, and Niacin as Skin Cancer Preventative Medications in Solid Organ Transplant Recipients, J. Am. Acad. Dermatol., ahead of print.","DOI":"10.1016\/j.jaad.2023.10.023"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaad.2020.04.160","article-title":"Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses","volume":"84","author":"Tee","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMc2303841","article-title":"Nicotinamide for Skin-Cancer Chemoprevention in Transplantation","volume":"388","author":"Schmults","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/24\/7619\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:36:43Z","timestamp":1760132203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/24\/7619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":50,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["jcm12247619"],"URL":"https:\/\/doi.org\/10.3390\/jcm12247619","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]}}}